Pharma Luminary, Dr Ismail Kola, Joins Forepont Capital Partners Venture Capital Team
https://www.businesswire.com/news/home/20190328005715/en/
NEW YORK--(BUSINESS WIRE)--Mar 28, 2019--Forepont Capital Partners is delighted to announce the appointment of Dr Ismail Kola as a senior partner in their Venture Capital Team. Additionally, Dr. Kola will lead Forepont’s Incubation Fund (FIF).
Dr Kola will play a key role in the conception and launch of Forepont’s next generation of pioneering biotechnology and life science companies as well as serve as an ongoing strategic resource for all companies in the Forepont ecosystem supporting their clinical development strategies. Additionally, he will serve on the board of directors of several portfolio companies. Dr Kola will join Forepont Capital Partners Investment Committee.